A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
This research study is investigating a new medication, known as Eloralintide (LY3841136), for adults living with overweight or obesity. It's an early-stage study, often called a 'Phase 1' study, which means the main goal is to find out how the medication acts inside the human body. Researchers will be looking at things like how the body absorbs, uses, and gets rid of the medication, as well as if there are any side effects. This kind of research is crucial to help scientists understand if a new medicine is safe and if it could potentially be helpful for treating conditions like overweight and obesity in the future. It's open to adults aged 18 and over, both men and women.
At a glance
What is this study about?
This study is exploring a new medicine called Eloralintide (LY3841136). The main aim is to understand how this medicine works in people who are overweight or obese. When scientists develop new medicines, they go through different stages of testing. This particular study is in the very early stages, sometimes called 'Phase 1'. This means it's one of the first times the medicine is being given to people, and the focus is on safety and how the body handles the medicine.
Being overweight or obese can impact your health in many ways, and researchers are always looking for new and effective ways to help people manage their weight. This study is an important step in learning if Eloralintide could eventually be a safe and useful treatment option. By taking part, you would be helping medical science gather important information about this new drug.
The study welcomes both men and women who are 18 years old or older. The research team will carefully monitor all participants to understand the effects of the medicine. Information gathered from studies like this helps doctors and scientists decide if a medicine should move on to larger and longer studies.
Key takeaways
- This is an early-stage study for a new medicine, Eloralintide (LY3841136).
- It's for adults (18+) who are overweight or obese.
- The main goal is to check the medicine's safety and how it works in the body.
- Participation involves regular visits and health checks.
- Potential risks and benefits will be fully discussed before you join.
- You can stop participating at any time.
Who may be eligible?
To join this study, you need to be an adult, 18 years old or older. The study is for people who are considered overweight or obese. This means your weight is higher than what is generally considered healthy for your height.
Both men and women can take part. There will be other specific health checks and requirements you'll need to meet to make sure the study is safe for you and that the results will be clear. For example, you might need to have certain blood test results or not be taking particular other medicines. All these details would be checked by the study doctor.
Before you can join, the study team will ask you questions about your health and do some tests. This is to make sure you are suitable for the study and that it's safe for you to take part. They will explain everything clearly, and you'll have the chance to ask any questions.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you consider yourself to be overweight or obese?
- Are you willing to attend regular appointments at a study clinic?
- Are you able to take study medication as directed?
- Are you comfortable having health checks like blood tests?
What does participation involve?
If you decide to take part in this study, you'll have a number of visits to the study clinic. These visits will involve various assessments, such as physical exams, blood tests, and possibly other tests to check your health and how the study medicine is affecting you. You will be given the study medication, Eloralintide (LY3841136), according to a specific plan set by the research team. This will likely involve regular doses over a certain period.
The total duration of your participation in the study, including all treatments and follow-up visits, will be explained in full detail by the study team. They will tell you how often you need to come in, how long each visit might take, and when your last follow-up appointment will be. This will ensure you understand the commitment involved before you agree to participate.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is Eloralintide (LY3841136)?
It's a new medicine being investigated for people who are overweight or obese. This study is an early step to understand how it works and if it's safe.
What does 'Phase 1 study' mean?
Phase 1 means it's an early study where the main goals are to check the medicine's safety, how it behaves in the body, and what dose might be best, often for the first time in humans.
Who can join this study?
Adults aged 18 and older who are either overweight or obese can potentially join. Both men and women are welcome, subject to other specific health checks.
Will I know if I'm getting the actual medicine?
In some studies, you might not know if you're getting the active medicine or a dummy pill (placebo). The study team will explain how this works for this particular trial before you agree to take part.
What if I change my mind about taking part?
You can leave the study at any time, for any reason, without it affecting your usual medical care. Taking part is always your choice.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.